PharmaEssentia (TWSE: 6446) today announced its net revenues for May 2025: On a consolidated basis, revenues for May 2025 were approximately NT$1.18 billion, a decrease of 3.82% from April 2025 and an increase of 49.15% from May 2024. The year-to-date consolidated revenue totaled NT$5.66 billion, an increase of 81.99%.